Literature DB >> 339724

Results of intraocular lens implant surgery. The third Binkhorst medal lecture.

N S Jaffe.   

Abstract

I compared an early series of 162 consecutive Copeland intraocular lens implants with a later series of 650 consecutive Binkhorst implants. Of the eyes with Copeland implants, 76.5% achieved 6/12 (20/40) or better visual acuity compared to 89.8% in the Binkhorst series. There was a striking difference in the incidence of clinically significant cystoid macular edema (less than 6/12 [20/40], visual acuity); 7.4% in the Copeland series and 1.4% in the Binkhorst series. I studied the Binkhorst series for visual acuity, causes of less than 6/12 (20/40) visual acuity, operative vitreous problems, additional surgery, secondary membranes, dislocations, and retinal detachment. A fluorescein angiographic study of 190 Binkhorst implants and 113 aphakic controls was done. There was a comparable incidence of cystoid macular edema in both groups at four, eight, and 16 to 24 months postoperatively. Extracapsular Binkhorst implants showed a lower incidence than intracapsular Binkhorst implants.

Entities:  

Mesh:

Year:  1978        PMID: 339724     DOI: 10.1016/s0002-9394(14)76659-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

Review 1.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  The human anterior lens capsule--an attempted chemical debridement of epithelial cells by ethylenediaminetetracetic acid (EDTA) and trypsin.

Authors:  R C Humphry; E G Davies; T J Jacob; G M Thompson
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

3.  Cytological factors relating to posterior capsule opacification following cataract surgery.

Authors:  T J Jacob; R C Humphry; E G Davies; G M Thompson
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.